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Abstract
Background: To remark the feasibility of endovascular treatment of an aorto-caval fistula in a old high risk patient
with “hostile” abdomen for previous surgeries.
Methods: In September 2009 a 81-years-old patient was admitted in emergency at our department because of
abdominal pain and massive oedema of the lower extremities associated to dyspnoea (New York Heart Association
(NYHA) functional class III). A CT scan showed an aorto-caval fistula involving the abdominal aorta below the renal
arteries. This abnormal communication was likely due to the previous abdominal surgeries, was complicated by
occlusion of the inferior vena cava at the diaphragm and was responsible for the massive oedema of the lower
extremities. Because of unstable conditions and hostile abdomen the patient was considered unfit for conventional
surgery and an endovascular approach was planned. After unsuccessful attempt by positioning of an Amplatzer
vascular ring into the fistula, a Medtronic covered stent-grafts were implanted from the renal arteries to the both
common iliac arteries. The patient had an impressive improvement characterized by a 18 Kg weight loss and a
complete restoration of the functional capacity (from NYHA class III to NYHA class I) associated to a complete
resolution of the lower extremities oedema as confirmed at the a month-CT-scan.
Conclusion: Endovascular surgery of aorto-caval fistula represents a good option in alternative to conventional
surgery mostly in old high risk patient.
Methods
In the year 2002 a 74 years-old man was diagnosed with
retroperitoneal fibrosis which had caused bilateral uret-
eral obstruction. The right kidney function was success-
fully restored by stent placement.
In the year 2003 the patient was subjected to left
nephrostomy to restore kidney function but the treatment
was complicated by capsular haematoma that was surgi-
cally removed. Thereafter the left kidney was not function-
ing anymore.
In October 2008 the patient was admitted to the emer-
gency room because of small bowel sub-obstruction and
underwent a surgical operation in order to remove the
fibrotic adherences causing the symptoms. Despite the
previous diagnosis, he had not been specifically treated
for the retroperitoneal fibrosis.
In September 2009 the patient arrived at our observa-
tion for the first time. He was admitted in the emer-
gency room because of abdominal pain and massive
oedema of the lower extremities associated to dyspnoea.
On arrival at our Department, the patient related dys-
pnoea, New York Heart Association (NYHA) functional
class III. He was awake and conversant. The pulse was 88
beats per minute and the blood pressure 150/80. The skin
was cool and dry. On physical examination, his oxygen
saturation was 96 % while he was breathing room air. He
had massive oedema of both lower extremities.
A CT scan was performed that evidenced retroperito-
neal fibrosis (figure 1A) as well as an aorto-caval fistula
involving the abdominal aorta below the renal arteries
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(figure 1B). This abnormal communication was likely due
to the previous abdominal surgeries which had caused a
hyatrogenic fistulous aorto-caval shunt. The inferior vena
cava was completely occluded few centimetres above the
communication with the aorta (figure 1B). This preserved
the patient from massive pulmonary hyperafflux and was
responsible for the massive oedema of the lower
extremities.
The majority of Aorto-Caval Fistulas occur sponta-
neously, with most resulting from the rupture of an exist-
ing AAA into the vena cava or as result from iatrogenic
injuries occurring during peripheral angiography, surgery
or other potential etiologies [1].
Symptomatic ACFs have traditionally been repaired
using open surgical techniques. These procedures can be
technically challenging, with significant intraoperative
blood loss and high operative morbidity and mortality
rates approaching 30% [2].
The hostile abdomen with age and heart failure are a
well recognized high-risk criteria for conventional surgery
leading to a minimally invasive approach.
Since the patient had a surgically “hostile abdomen” due
to retroperitoneal fibrosis, we decided to percutaneously
treat the aorto-caval communication [3]. We selectively
cannulated the aorto-caval fistula originating in the ante-
rior wall of the aorta with a 7 FR guiding catheter and
implanted an AMPLATZER® Vascular Plug II (AGA
Medical Corporation), which is a unique multi-segmented,
multi-layered design nitinol plug that significantly reduces
occlusion time for transcatheter embolization procedures.
The three adjustable lobes of the AMPLATZER Vascular
Plug II are designed for enhanced conformability to vessel
landing zones. We obtained a good angiographic result
with almost complete abolishment of the shunt. In 3 days
the patient had a 9 Kg weight loss associated to a signifi-
cant reduction of the lower extremities oedema and of the
dyspnoea.
One month later the patient was regaining weight and
there was a worsening of the symptoms. A new CT scan
was performed which showed recurrence of the aorto-
caval communication which was likely due to an addi-
tional fistula that was not closed with the initial procedure.
The CT scan also showed the Amplatzer vascular plug still
in correct position (fig. 2).
We therefore performed a new aortogram confirming
the recurrence of the aorto-caval communication with
the major shunt originating in the posterolateral left wall
of the aorta. In order to obtain a complete occlusion of
the aorto-caval communication, we decided to implant
an aortic prosthesis Talent (Medtronic). The TalentTM
Abdominal Stent Graft is designed to treat abdominal
aortic aneurysms using a minimally invasive procedure
called endovascular stent grafting. It is used to reinforce
the weakened wall of the vessel to prevent the aneurysm
from rupturing. The Talent Stent Graft is a woven polye-
ster tube supported by a tubular metal web that expands
to a pre-established diameter when placed in the artery
[4,5].
We first implanted an aortic stent graft that covered the
abdominal aorta starting below the renal arteries and land-
ing right before the aortic bifurcation. However, a residual
shunt was still present. This residual fistulous communica-
tion was completely abolished by implanting an additional
Talent device which would cover the abdominal aorta and
both the iliac arteries. The patient had an impressive clini-
cal course characterized by a 18 Kg weight loss and a
Figure 1 A Retroperitoneal fibrosis demonstrated at CT scan B Aorto-caval fistula originating from the abdominal aorta below the renal arteries
(double arrow). The inferior vena cava (arrow) was completely occluded few centimetres above the communication with the aorta.
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complete restoration of the functional capacity (from
NYHA class III to NYHA class I) associated to a complete
resolution of the lower extremities oedema. The patient
also initiated a specific therapy for retroperitoneal fibrosis
with steroids and tamoxifen. The CT scan performed one
month later showed a complete abolishment of the shunt
with no opacization of the inferior vena cava from the
abdominal aorta (Figure 3). The Amplatzer vascular plug
was excluded from the blood flow after the endoprosthesis
implantation (Figure 3).
Conclusion
Idiopathic retroperitoneal fibrosis (IRPF) is a syndrome
of unknown cause that typically presents with constitu-
tional symptoms and back or abdominal pain. Ureteral
obstruction is present in as many as 80% to 100% of
reported cases. However, intestinal or bilary-pancreatic
[6-8] or magnetic resonance imaging often shows peri-
aortic soft tissue accumulation that encases the distal
aorta below the renal arteries, as well as nearby structures
[9-13].
The initial approach often requires surgical, urological,
or medical intervention to address anatomic complica-
tions. For instance, ureteral obstruction usually respond to
stent placement, bowel obstruction requires evaluation,
observation and even diversion. However, when these
complications have been addressed, medical treatment can
be devised to treat the acute inflammation and suppress
what appears to be a more chronic immunologic process
with subsequent fibrosis.
In the present case, the previous surgical interventions
had caused a hyatrogenic aorto-caval communication in
Figure 2 The CT scan at 1 month follow-up after vascular plug implantation showed recurrence of the aorto-caval communication. The
Amplatzer vascular plug, still in correct position, was not able to halt the fistulous communication.
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a patient that had developed a very hostile abdomen to
be treated with an additional surgical approach. Since
the fistulous shunt was causing very important and life
threatening symptoms, we decided to percutaneously
intervene before starting an appropriate medical therapy.
In fact, any kind of intervention for IRPF does not
reduce long term prognosis if not associated to specific
pharmacological therapy.
We first decided to close the abnormal communica-
tion by using a less invasive approach implanting an
endovascular plug usually dedicated to vessel emboliza-
tion. Previous experience have been reported treating
aorto-caval fistulas with vascular plug implantation.
However, the few cases reported in the literature refer
to either fistulous communication resulting from a sur-
gical intervention for aortic aneurysm or congenital
aorto-caval fistula [3,14,15]. The present case was com-
plicated from the presence of IRPF which would prob-
ably have caused multiple and complicated abnormal
communication.
In fact, although the result was initially encouraging,
the unfortunate recurrence of an important shunt aggra-
vating the symptoms led us to consider an aortic endo-
prosthesis to definitely treat the inferior vena cava
volume overload [16]. Aortic endoprosthesis have been
successfully used to close aorto-caval communication in
patients with either ruptured or dissected aortic aneur-
ysm or penetrating abdominal trauma [2,17-21].
Figure 3 The CT scan 1 month after aortic endoprosthesis implantation showed a complete abolishment of the shunt with no opacization of
the inferior vena cava from the abdominal aorta . The Amplatzer vascular plug was excluded from the aortic blood flow after the
endoprosthesis implantation.
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Aortic endoprosthesis implantation in the present case
successfully treated the abnormal shunt resolving both
lower extremities oedema and dyspnoea.
This is the first demonstration that such a percuta-
neous approach can be successfully used to treat a very
complicated case of aorto-caval fistula with a device that
is commonly used to treat aortic aneurysms.
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